Δ9-Tetrahydrocannabinol increases proopiomelanocortin gene expression in the arcuate nucleus of the rat hypothalamus
- 4 April 1997
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 323 (2-3) , 193-195
- https://doi.org/10.1016/s0014-2999(97)00144-1
Abstract
No abstract availableKeywords
Funding Information
- Comunidad de Madrid
- Ministerio de Educación, Cultura y Deporte
This publication has 10 references indexed in Scilit:
- A role for central cannabinoid and opioid systems in peripheral Δ9-tetrahydrocannabinol-induced analgesia in miceEuropean Journal of Pharmacology, 1996
- Anandamide decreases naloxone-precipitated withdrawal signs in mice chronically treated with morphineNeuropharmacology, 1995
- Activation of multiple transcription factor genes by tetrahydrocannabinol in rat forebrainNeuroReport, 1994
- δ-9-Tetrahydrocannabinol regulates substance P and enkephalin mRNAs levels in the caudate-putamenEuropean Journal of Pharmacology: Molecular Pharmacology, 1994
- Quantitative in situ hybridization histochemistry reveals increased levels of corticotropin-releasing factor mRNA after adrenalectomy in ratsNeuroscience Letters, 1986
- Characterization of pro-ACTH/endorphin-derived peptides in rat hypothalamusJournal of Neuroscience, 1986
- Anatomy and physiology of the neuroendocrine arcuate nucleusPeptides, 1985
- Pro-opiocortin fragments in human and rat brain: β-endorphin and α-MSH are the predominant peptidesBrain Research, 1980
- Structure and Biosynthesis of Pro-Adrenocorticotropin/Endorphin and Related Peptides*Endocrine Reviews, 1980
- Naloxone-induced or postwithdrawal abstinence signs in ?9-Tetrahydrocannabinol-Tolerant ratsPsychopharmacology, 1977